Improved delivery of ipratropium bromide/fenoterol from Respimat® Soft Mist Inhaler in patients with COPDKILFEATHER, S. A; PONITZ, H. H; BECK, E et al.Respiratory medicine. 2004, Vol 98, Num 5, pp 387-397, issn 0954-6111, 11 p.Article

A randomized study of tiotropium Respimat® Soft Mist™ Inhaler vs. ipratropium pMDI in COPDVOSHAAR, T; LAPIDUS, R; MALEKI-YAZDI, R et al.Respiratory medicine. 2008, Vol 102, Num 1, pp 32-41, issn 0954-6111, 10 p.Article

Effect of Switching Tiotropium HandiHaler^® to Respimat^® Soft Mist^™ Inhaler in Patients with COPD: The Difference of Adverse Events and Usability Between Inhaler DevicesASAKURA, Yuka; NISHIMURA, Naoki; MAEZAWA, Kayoko et al.Journal of aerosol medicine and pulmonary drug delivery. 2013, Vol 26, Num 1, pp 41-45, issn 1941-2711, 5 p.Article

Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat® Soft Mistinhaler: Results of phase II single-dose crossover studiesKOEHLER, D; PAVIA, D; DEWBERRY, H et al.Respiration (Basel). 2004, Vol 71, Num 5, pp 469-476, issn 0025-7931, 8 p.Article

A review of the development of Respimat® Soft Mist InhalerDALBY, R; SPALLEK, M; VOSHAAR, T et al.International journal of pharmaceutics. 2004, Vol 283, Num 1-2, pp 1-9, issn 0378-5173, 9 p.Article

ISAM 12th biennial congress symposium New advances in propellant-free inhaled drug delivery, Vienna, Austria, June 15, 1999Journal of aerosol medicine. 1999, Vol 12, issn 0894-2684, 43 p., SUP1Conference Proceedings

Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat® soft mist inhalerHODDERA, Rick; PAVIA, Demetri; DEWBERRY, Helen et al.Respiratory medicine. 2005, Vol 99, Num 9, pp 1087-1095, issn 0954-6111, 9 p.Article

Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizerNEWMAN, S. P; STEED, K. P; READER, S. J et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 9, pp 960-964, issn 0022-3549Article

Inhaled ethanolic and aqueous solutions via respimat soft mist inhaler are well-tolerated in asthma patientsPATEL, K. R; PAVIA, D; LOWE, L et al.Respiration (Basel). 2006, Vol 73, Num 4, pp 434-440, issn 0025-7931, 7 p.Article

Efficacy and safety of ipratropium bromide/ albuterol delivered via Respimat^® inhaler versus MDIZUWALLACK, R; DE SALVO, M. C; WOOD, C. C et al.Respiratory medicine. 2010, Vol 104, Num 8, pp 1179-1188, issn 0954-6111, 10 p.Article

Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat® Soft Mist Inhaler vs. a conventional metered dose Inhaler plus spacer in children with asthmaVON BERG, Andrea; JEENA, Prakash M; SOEMANTRI, Peter A et al.Pediatric pulmonology. 2004, Vol 37, Num 3, pp 264-272, issn 8755-6863, 9 p.Article

Fenoterol delivery by Respimat® soft mist inhaler versus CFC metered dose inhaler: Cumulative dose-response study in asthma patientsVINCKEN, Walter; DEWBERRY, Helen; MOONEN, Diane et al.The Journal of asthma. 2003, Vol 40, Num 6, pp 721-730, issn 0277-0903, 10 p.Article